Organon (OGN) Cash from Discontinued Operations (2020 - 2021)

Organon (OGN) posted quarterly Cash from Discontinued Operations of 356000000.0 for Q3 2021, up 173.85% year-over-year from 130000000.0 in Q3 2020, and up 2077.78% on a QoQ basis from 18000000.0 in Q2 2021.

Organon (OGN) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

Organon (OGN) has reported Cash from Discontinued Operations for 2 consecutive years, with 356000000.0 the latest figure, recorded in Q3 2021.

  • In Q3 2021, Cash from Discontinued Operations rose 173.85% year-over-year to 356000000.0; the TTM figure through Jun 2022 stood at 356000000.0 (up 216.72% YoY), while the FY2021 annual figure was 298000000.0, up 215.5% from the prior year.
  • Cash from Discontinued Operations came in at 356000000.0 for Q3 2021 at Organon, up from 18000000.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 356000000.0 in Q3 2021, with the low at 377000000.0 in Q4 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 3.36 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 356.00 Mn
Sep 30, 2021 356.00 Mn
Jun 30, 2021 -18.00 Mn
Jun 30, 2021 -18.00 Mn
Mar 31, 2021 -40.00 Mn
Mar 31, 2021 -40.00 Mn
Dec 31, 2020 -377.00 Mn
Dec 31, 2020 -377.00 Mn
Sep 30, 2020 130.00 Mn
Sep 30, 2020 130.00 Mn
Jun 30, 2020 70.00 Mn
Jun 30, 2020 70.00 Mn
Mar 31, 2020 -81.00 Mn
Mar 31, 2020 -81.00 Mn